Denali Therapeutics Inc. Cash Flow Statement

Cash Flow Statement Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -87.43M-88.19M-36.24M-197.61M71.14M-290.58M-325.99M-145.22M-422.77M
Share-based Compensation 2.95M4.41M18.79M38.38M50.35M85.25M99.85M108.10M102.88M
Gains from Investment Securities 0.50M-0.00M0.04M0.35M-0.04M0.21M-0.06M0.00M32.34M
Cash from Operations -71.91M-76.64M50.12M-151.58M416.15M-211.39M-244.72M-357.99M-347.69M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles -0.30M-0.75M2.71M5.02M-0.06M-8.75M1.20M
Depreciation & Amortization (CF) 1.50M3.10M7.42M8.00M8.53M8.60M10.40M16.73M7.80M
Change in Working Capital
Change in Account Payables 0.16M0.21M-0.53M1.03M-1.62M3.71M2.27M2.43M1.44M
Change in Accured Expenses 5.36M3.58M9.11M1.50M22.11M4.73M10.92M2.65M17.38M
Investing Activities
Capital Expenditures 6.13M2.88M3.39M17.92M3.10M8.50M17.83M12.94M15.91M
Change in Acquisitions & Divestments 14.00M141.50M273.90M535.33M665.36M1409.81M991.49M2075.95M1157.12M
Cash from Investing Activities -219.00M-41.17M-287.42M147.71M-623.21M-21.63M-141.39M249.31M-88.76M
Financing Activities
Other financing activities 1.34M
Change in Capital Stock
Shares Issued 0.11M265.62M4.00M6.19M193.95M19.35M296.21M17.82M499.25M
Preferred Shares Issued 300.37M29.97M
Misc.
Cash from Financing Activities 300.48M296.32M97.02M6.19M634.75M19.35M310.67M17.82M484.30M
Change in Cash 9.56M178.52M-140.29M2.33M427.69M-213.67M-75.43M-90.86M47.85M
Free Cash Flow -78.04M-79.51M46.72M-169.50M413.06M-219.89M-262.55M-370.93M-363.61M
Net Cash Flow 9.56M178.52M-140.29M2.33M427.69M-213.67M-75.43M-90.86M47.85M